Stefanie Hayoz

Also affiliated with Swiss Group For Clinical Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY”.

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY

Hematological Oncology(2023)10.1002/hon.3163_80

N/A

0DataRank · unranked

3 citations

Maria Cristina Pirosa, Sämi Schär, Marianne Brodtkorb, Björn E. Wahlin, Micaela Hernberg +19 more

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Annals of Oncology(2025)10.1016/j.annonc.2025.01.017

N/A

0DataRank · unranked

16 citations

Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski +28 more